Difficulties of setting efficacy endpoints in early-stage clinical trials of brain tumor drugs
Clinical trials for cancer drugs have three stages, Phase I–III, before marketing, each with different evaluation items. However, there is no consensus on the appropriateness of evaluation criteria for early-stage clinical ...